NovoCure (NVCR) Selling, General & Administrative (2014 - 2026)
NovoCure (NVCR) Selling, General & Administrative (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 369.70 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 39.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.91 Mn |
| Mar 31, 2026 | 85.85 Mn |
| Dec 31, 2025 | 43.02 Mn |
| Sep 30, 2025 | 45.92 Mn |
| Jun 30, 2025 | 43.96 Mn |
| Mar 31, 2025 | 44.77 Mn |
| Dec 31, 2024 | 72.48 Mn |
| Sep 30, 2024 | 40.10 Mn |
| Jun 30, 2024 | 37.71 Mn |
| Mar 31, 2024 | 39.53 Mn |
| Dec 31, 2023 | 39.45 Mn |
| Sep 30, 2023 | 41.89 Mn |
| Jun 30, 2023 | 40.78 Mn |
| Mar 31, 2023 | 41.94 Mn |
| Dec 31, 2022 | 38.07 Mn |
| Sep 30, 2022 | 32.51 Mn |
| Jun 30, 2022 | 31.67 Mn |
| Mar 31, 2022 | 30.51 Mn |
| Dec 31, 2021 | 31.01 Mn |
| Sep 30, 2021 | 31.23 Mn |